News

Screening cuts bowel cancer rate

07-Dec-07

Bowel cancer screening halves the number of emergency admissions for the disease and significantly cuts death rates, according to UK research.

Findings highlight the importance of the national bowel cancer screening programme, which currently targets those aged 60 to 69 across England.

The screening programme will be extended from 2012 to include men and women aged 70 to 75, as part of the NHS National Cancer Strategy, which was published by the DoH this week.

In the latest study, researchers looked at the impact of two pilot bowel cancer screening programmes launched in Coventry and Warwickshire in 1999.

The number of emergency admissions for bowel cancer and the number of deaths within 30 days of admission to the largest hospital trust in the Midlands over five years were analysed.

In this time, 1,236 bowel cancer patients were admitted to hospital as an emergency.

At the start of the study, just under 30 per cent of the bowel cancer patients had to be admitted as an emergency.

However, once the screening programme had been in place for five years this figure halved to just 15 per cent.

Before the launch of the screening programmes, 48 per cent of those undergoing emergency surgery for bowel cancer died. But after the launch of the screening programme this figure fell to just 13 per cent.

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

How to apply for your certificate

Applying to the RCGP for your CCT recommendation now takes three clicks, writes Fiona Erasmus. Read more

A question of capacity

Medicolegal advisor, Dr John Holden addresses some dilemmas on consent that may be faced by GPs. Read more

Workplace-based assessment

The WPBA should be seen as a developmental process, says the RCGP's Dr Jane Mamelok. Read more

Show all articles

 

Latest Clinical Articles

Endometriosis

Contributed by Mr Michael Booker, consultant obstetrician & gynaecologist, and fertility specialist ... Read more

Primary hyperparathyroidism

Contributed by Mr David Scott-Coombes, consultant endocrine surgeon at the University Hospital of Wa... Read more

Clinical Review - Headache in children

Contributed by Dr David Kernick, a GPSI in headache, based in Exeter. Read more

Show all clinical articles

MIMS Product News

Toviaz

New drug - Toviaz

Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more

New drug - Tasigna

Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more

Ciproxin licensed for UTI in children

The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more

Jobs

 

Job of the Week